Have a personal or library account? Click to login
Primary care system factors and clinical decision-making in patients that could have lung cancer: A vignette study in five balkan region countries Cover

Primary care system factors and clinical decision-making in patients that could have lung cancer: A vignette study in five balkan region countries

Open Access
|Jan 2022

Figures & Tables

Figure 1

National comparisons of PCPs stated clinical actions for vignette of a patient with symptoms that could be due to lung cancer.
National comparisons of PCPs stated clinical actions for vignette of a patient with symptoms that could be due to lung cancer.

Number of participants and response rates in each of the five participating countries_

BulgariaCroatiaGreeceRomaniaSlovenia
Number of respondents596768177104
Number invited90292318Unknown352
Response rate (%)65.622.921.4Unknown29.5

Effects of PCP and practice demographics, system factors, availability of relevant investigations and country on (a) PCPs’ likelihood of scheduling an investigation and (b) likelihood of referral patients to a specialist, for a patient with symptoms that could be due to lung cancer_

Statementa) Effects on PCPs’ likelihood of organising an investigation
b) Effects on PCPs’ likelihood of referral to a specialist
Exp(B)95% CIP valueExp(B)95% CIP value
Sex (Male)0.9120.478-1.7420.7810.8060.406-1.5990.536
Type of practice (Urban) 0.899 0.515
Rural0.8230.424-1.5960.5641.5550.802-3.0150.191
Island1.3120.264-6.5210.7402.1980.422-11.4590.350
Mixed1.0280.486-2.1740.9431.1010.470-2.5800.824
Years since graduation (Less than 10) 0.474 0.975
10 to 190.9480.354-2.5410.9161.2590.438-3.6160.669
20 to 290.6970.267-1.8180.4611.1050.398-3.0630.848
30 to 391.4650.505-4.2490.4821.2120.405-3.6290.732
40 or more1.1170.201-6.2160.9000.7840.129-4.7760.792
‘Common presentations are 0.731 0.662
covered by local or national
guidelines’ (Strongly disagree)
Disagree2.0170.490-8.2960.3311.0000.254-3.9401.000
Neither agree nor disagree1.5720.416-5.9360.5041.1590.316-4.2460.824
Agree2.1620.573-8.1620.2551.5270.423-5.5170.518
Strongly agree1.5480.317-7.5470.5890.7890.152-4.1050.778
‘We have access to a fast-track specialist 0.324 0.318
appointment system’ (Strongly disagree)
Disagree0.9040.371-2.2020.8250.6470.266-1.5770.338
Neither agree nor disagree1.9600.655-5.8620.2291.0150.366-2.8090.978
Agree0.8400.329-2.1450.7160.8330.320-2.1690.708
Strongly agree1.8850.465-7.6400.3752.1300.572-7.9310.259
‘Patients can self-refer to 0.263 0.910
specialists’ (Strongly disagree)
Disagree1.4070.755-2.6210.2831.1500.588-2.2470.683
Neither agree nor disagree0.9410.377-2.3480.8961.1900.470-3.0130.713
Agree3.6760.979-13.8070.0540.8680.341-2.2120.768
Strongly agree2.0590.474-8.9520.3351.6960.414-6.9550.463
Number of relevant investigations 0.376 0.257
available (None)
One0.2500.024-2.6220.2480.1600.028-0.9070.038
Two0.3650.043-3.1040.3560.3580.091-1.4040.141
Three0.7630.049-11.9520.8470.5520.065-4.6540.585
Four0.5520.060-5.0690.5990.1980.042-0.9290.040
Five0.2570.027-2.4000.2330.2510.049-1.2850.097
Country (Bulgaria) <.001 <0.001
Croatia0.1880.062-0.5720.0030.2860.098-0.8400.023
Greece0.6570.179-2.4140.5270.1600.042-0.6110.007
Romania1.6000.544-4.7050.3933.4731.544-7.8130.003
Slovenia0.2100.063-0.6940.0110.3450.115-1.0330.057
Constant7.205 0.1451.349 0.781

PCPs’ levels of agreement with statements on health system factors that could influence the timeliness of cancer diagnosis_

StatementMean Likert scores (SD)1
Significance
BulgariaCroatiaGreeceRomaniaSlovenia (P value)
‘Common presentations and advice to which to refer are covered by local or national guidelines’2.76 (1.01)3.22 (0.98)3.59 (1.01)3.37 (1.00)3.73 (0.84)<0.001
‘We have access to a fast- track specialist appointment system if cancer is suspected’2.71 (1.19)3.22 (1.17)2.45 (1.11)2.58 (1.08)3.22 (1.22)<0.001
‘Patients can self-refer to specialists, so GPs don’t need to act as gatekeepers.’2.39 (1.04)2.04 (1.02)2.58 (1.30)2.38 (1.15)1.55 (0.85)<0.001

Participants’ demographic and practice information for each of the five participating countries_

Bulgaria n (%)Croatia n (%)Greece n (%)Romania n (%)Slovenia n (%)
SexMale13 (22.0)12 (17.9)34 (50.0)21 (11.9)25 (24.0)
Female44 (74.6)54 (80.6)34 (50.0)154 (87.0)78 (75.0)
Not given2 (3.4)1 (1.5)0 (0.0)2 (1.2)1 (1.0)
Years sinceLess than 108 (13.6)11 (16.4)0 (0.0)8 (4.5)17 (16.3)
graduation10 to 1911 (18.6)10 (14.9)38 (55.9)42 (23.7)34 (32.7)
20 to 2923 (39.0)22 (32.8)25 (36.8)75 (42.4)32 (30.8)
30 to 3911 (18.6)21 (31.3)5 (7.4)50 (28.2)16 (15.4)
40 or more5 (8.5)1 (1.5)0 (0.0)0 (0.0)5 (4.8)
Not given1 (1.7)2 (3.0)0 (0.0)2 (1.1)0 (0.0)
Type of practiceUrban44 (74.6)31 (46.3)20 (29.4)108 (61.0)44 (42.3)
Rural5 (8.5)23 (34.3)34 (50.0)60 (33.9)31 (29.8)
Mixed9 (15.3)13 (19.4)14 (20.6)7 (4.0)29 (27.9)
Not given1 (1.7)0 (0.0)0 (0.0)2 (1.1)0 (0.0)
Number of PCPs132 (54.2)33 (49.3)24 (35.3)64 (36.2)7 (6.7)
in the practice28 (13.6)9 (19.4)8 (11.8)33 (18.6)10 (9.6)
38 (13.6)6 (9.0)3 (4.4)17 (9.6)14 (13.5)
4-51 (1.7)6 (9.0)11 (16.2)20 (11.3)10 (9.6)
6-71 (1.7)6 (9.0)6 (8.8)9 (5.1)12 (11.5)
8-91 (1.7)5 (7.5)1 (1.5)5 (2.8)15 (14.4)
10 or more7 (11.9)2 (3.0)13 (19.1)22 (12.4)36 (34.6)
Not given1 (1.7)0 (0.0)2 (2.9)7 (4.0)0 (0.0)

Number of PCPs who have direct access to relevant imaging for lung cancer_

Bulgaria n (%)Croatia n (%)Greece n (%)Romania n (%)Slovenia n (%)Significance (P value)
Plain X-ray54 (91.5)64 (95.5)66 (97.1)149 (84.2)90 (86.5)<0.006
CT and/or PET CT and/or MRI7 (11.9)16 (23.9)53 (77.9)23 (13.0)71 (68.3)<0.001
DOI: https://doi.org/10.2478/sjph-2022-0007 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Language: English
Page range: 40 - 47
Submitted on: Dec 21, 2020
|
Accepted on: Nov 19, 2021
|
Published on: Jan 3, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Davorina Petek, Radost Assenova, Gergana Foreva, Svjetlana Gašparović Babić, Marija Petek Šter, Nuša Prebil, Aida Puia, Emmanouil Smyrnakis, Michael Harris, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.